Steris buys Xodus Medical to expand surgical consumables
Alpha Vantage · GuruFocus · · AI-summarised by FinFlash
Steris PLC announced the acquisition of Xodus Medical, expanding its surgical consumables portfolio and patient safety offerings. GuruFocus rates Steris modestly undervalued by 18.8%, with a GF Score of 90/100 reflecting strong financial health, profitability and growth. Analysts carry a $263.12 average target versus a $214.40 price, implying 22.7% upside, with seven buy ratings.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.